BRIEF published on 09/10/2025 at 06:50, 1 year ago Galenica Enters Diagnostics with Labor Team Acquisition Acquisition Diagnostics Galenica AG Healthcare Network Labor Team
PRESS RELEASE published on 09/10/2025 at 06:45, 1 year ago Launch of Galenica Diagnostics: Acquisition of Labor Team completed Galenica completes acquisition of Labor Team, forming Galenica Diagnostics. Fourth-largest Swiss lab to operate under Galenica. Board members merge Galenica and lab expertise Acquisition Switzerland Galenica Diagnostics Labor Team
BRIEF published on 08/07/2025 at 06:50, 1 year 1 month ago Galenica AG: Half-year growth and upward revision of EBIT forecasts Adjusted EBIT Prescription Drugs Galenica Growth Health Products And Services Swiss Pharmaceutical Market
PRESS RELEASE published on 08/07/2025 at 06:45, 1 year 1 month ago Galenica demonstrates pleasing growth and improves EBIT guidance Galenica AG demonstrates pleasing growth with 5.0% increase in Group sales, raising EBIT guidance by 7%-9%. Adjusted EBIT grows by 10.9% in the first half of 2025 Growth EBIT Guidance Galenica AG Group Sales First Half 2025
BRIEF published on 07/02/2025 at 06:50, 1 year 2 months ago Galenica Acquires Labor Team to Enter Diagnostics Business Acquisition Galenica Diagnostics Healthcare Network Labor Team
PRESS RELEASE published on 07/02/2025 at 06:45, 1 year 2 months ago Galenica to enter the diagnostics business by acquiring Labor Team Galenica AG acquires Labor Team, a leading Swiss diagnostic service provider, expanding its offerings in the physicians segment and entering the diagnostics business Acquisition Galenica AG Healthcare Network Labor Team Diagnostics Business
BRIEF published on 05/22/2025 at 06:50, 1 year 3 months ago Galenica Reports Solid Sales Growth in Early 2025 Retail Expansion Pharmaceutical Market Logistics & IT Galenica Growth Products & Care
PRESS RELEASE published on 05/22/2025 at 06:45, 1 year 3 months ago Galenica continues sales growth Galenica reports 4.7% sales growth to CHF 1,314.2 million in 2025, outperforming the pharmaceutical market. Guidance confirms sales growth of 3-5% and EBIT growth of 4-6% Sales Growth EBIT Growth Galenica Pharmaceutical Market 2025 Outlook
BRIEF published on 04/10/2025 at 18:17, 1 year 5 months ago Galenica Annual General Meeting Embraces All Motions Switzerland Dividend Increase Board Elections Galenica AGM 2025
PRESS RELEASE published on 04/10/2025 at 18:12, 1 year 5 months ago Galenica Annual General Meeting approves all motions and elects new member of the Board of Directors Galenica Annual General Meeting approves all motions, elects new Board member, and approves dividend increase. Shareholders demonstrate confidence in leadership and strategic direction Board Of Directors Annual General Meeting Dividend Increase AGM Galenica
Published on 09/21/2026 at 15:45, 5 hours 16 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 6 hours 41 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 6 hours 56 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 7 hours 1 minute ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 7 hours 16 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 20:34, 27 minutes ago BRANICKS Group AG: Regular interest payment on EUR 400 million bond to be made as scheduled – Completion of maturity extension imminent
Published on 09/21/2026 at 18:00, 3 hours 1 minute ago Cham Swiss Properties places bond of CHF 100 million
Published on 09/21/2026 at 17:45, 3 hours 16 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 3 hours 16 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 17:00, 4 hours 1 minute ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 18:19, 2 hours 42 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 3 hours ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 3 hours 15 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 07:00, 14 hours 1 minute ago Peugeot Invest takes a stake in Mérieux NutriSciences
